Published in Clin Cancer Res on November 17, 2009
Penile cancer: current therapy and future directions. Ann Oncol (2013) 1.54
Activation of postnatal neural stem cells requires nuclear receptor TLX. J Neurosci (2011) 1.04
Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events. Stat Med (2015) 0.86
MCM Paradox: Abundance of Eukaryotic Replicative Helicases and Genomic Integrity. Mol Biol Int (2014) 0.85
Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study. J Transl Med (2013) 0.84
DNA replication in eukaryotic cells. Annu Rev Biochem (2001) 13.39
Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer (2005) 6.46
Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol (2005) 5.82
SQUAMOUS-CELL EPITHELIOMA OF THE SKIN: A STUDY OF 256 CASES. Ann Surg (1921) 4.59
Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ (1992) 2.99
Replication licensing--defining the proliferative state? Trends Cell Biol (2002) 2.91
Replication licensing and cancer--a fatal entanglement? Nat Rev Cancer (2008) 2.86
Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A (1998) 2.61
Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res (1999) 2.49
Linking oncogenic pathways with therapeutic opportunities. Nat Rev Cancer (2006) 2.32
Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol (2005) 2.31
DNA replication licensing and human cell proliferation. J Cell Sci (2001) 2.30
Cdc6 protein causes premature entry into S phase in a mammalian cell-free system. EMBO J (1998) 1.95
Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol (2008) 1.70
Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res (2005) 1.50
Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst (2002) 1.48
Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am (1992) 1.47
Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res (2001) 1.34
Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet (1999) 1.24
Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am J Pathol (2002) 1.24
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol (2003) 1.24
Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol (1993) 1.23
Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer (2003) 1.22
DNA replication licensing in somatic and germ cells. J Cell Sci (2004) 1.21
EAU Guidelines on Penile Cancer. Eur Urol (2004) 1.19
Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol (1993) 1.19
A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines. BJU Int (2006) 1.15
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer (2005) 1.12
Cell cycle markers in clinical oncology. Curr Opin Cell Biol (2007) 1.12
1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology. Anal Cell Pathol (1998) 1.11
Translational approaches to improving cervical screening. Nat Rev Cancer (2003) 1.10
Morbidity following groin dissection for penile carcinoma. Br J Urol (1993) 1.10
Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. Br J Cancer (2009) 1.08
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells. Exp Cell Res (2005) 1.07
Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis. J Urol (2006) 1.05
Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. Br J Cancer (2009) 1.04
Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma. Clin Cancer Res (2009) 0.98
Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates. Br J Cancer (2004) 0.97
DNA replication licensing and cell cycle kinetics of oligodendroglial tumours. Br J Cancer (2004) 0.96
DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. Clin Cancer Res (2007) 0.95
Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm: a report of 20 cases. Am J Surg Pathol (1998) 0.95
Cdc6 is a rate-limiting factor for proliferative capacity during HL60 cell differentiation. Exp Cell Res (2007) 0.93
Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. Br J Cancer (2007) 0.92
Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates. Br J Cancer (2008) 0.89
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J Urol (2006) 0.88
Improved screening for anal neoplasia by immunocytochemical detection of minichromosome maintenance proteins. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Penile squamous cell carcinoma: anatomic, pathologic and viral studies in Paraguay (1993-2007). Anal Quant Cytol Histol (2007) 0.87
DNA replication licensing in peripheral B-cell lymphoma. J Pathol (2005) 0.87
Subtypes of oligodendroglioma defined by 1p,19q deletions, differ in the proportion of apoptotic cells but not in replication-licensed non-proliferating cells. Acta Neuropathol (2006) 0.81
Stopping replication, at the beginning. Nat Chem Biol (2008) 0.78
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol (2012) 6.09
Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol (2012) 3.01
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis (2009) 2.78
Characterizing clinically significant prostate cancer using template prostate mapping biopsy. J Urol (2011) 2.61
Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial. Ann Intern Med (2010) 2.55
Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures. BJU Int (2006) 2.42
Case-mix and variation in specialist referrals in general practice. Br J Gen Pract (2005) 2.29
Simultaneous penile lengthening and penile prosthesis implantation in patients with Peyronie's disease, refractory erectile dysfunction, and severe penile shortening. J Sex Med (2011) 2.20
Long-term trends in incidence, survival and mortality of primary penile cancer in England. Cancer Causes Control (2013) 2.18
What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int (2005) 1.95
Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother (2007) 1.91
Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol (2009) 1.87
Association between practice size and quality of care of patients with ischaemic heart disease: cross sectional study. BMJ (2003) 1.83
Pedicled pubic phalloplasty in females with gender dysphoria. BJU Int (2005) 1.76
The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int (2010) 1.74
Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells. J Urol (2003) 1.74
Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study. BMJ (2009) 1.73
The cell cycle and cancer. J Pathol (2011) 1.67
Penile suspensory ligament division for penile augmentation: indications and results. Eur Urol (2006) 1.67
Small-molecule mimics of an alpha-helix for efficient transport of proteins into cells. Nat Methods (2007) 1.61
Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res (2005) 1.50
Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst (2002) 1.48
Analysis of the outcome of intracytoplasmic sperm injection using fresh or frozen sperm. BJU Int (2011) 1.46
Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer. Int J Cancer (2014) 1.45
Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation. BJU Int (2014) 1.42
Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. Radiology (2013) 1.39
Aromatic amino acids required for pili conductivity and long-range extracellular electron transport in Geobacter sulfurreducens. MBio (2013) 1.34
Plexin-B1 mutations in prostate cancer. Proc Natl Acad Sci U S A (2007) 1.28
Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol (2013) 1.27
A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer. PLoS One (2010) 1.26
Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet (2002) 1.24
Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol (2012) 1.23
Essential helix interactions in the anion transporter domain of prestin revealed by evolutionary trace analysis. J Neurosci (2006) 1.22
Commitment point during G0-->G1 that controls entry into the cell cycle. Mol Cell Biol (2003) 1.21
DNA replication licensing in somatic and germ cells. J Cell Sci (2004) 1.21
BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro. J Urol (2003) 1.20
The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur Urol (2008) 1.19
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol (2012) 1.18
Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle. Proc Natl Acad Sci U S A (2011) 1.18
Yohimbine in the treatment of orgasmic dysfunction. Asian J Androl (2007) 1.17
A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines. BJU Int (2006) 1.15
Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J Biol Chem (2004) 1.14
Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory? Eur J Cardiovasc Prev Rehabil (2004) 1.14
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. Diagn Microbiol Infect Dis (2009) 1.13
Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations. J Clin Endocrinol Metab (2006) 1.12
Cell cycle markers in clinical oncology. Curr Opin Cell Biol (2007) 1.12
Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study. Cancer (2012) 1.11
Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol (2012) 1.10
Hexameric ring structure of human MCM10 DNA replication factor. EMBO Rep (2007) 1.10
P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur Urol (2004) 1.10
Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study. Arthritis Rheum (2006) 1.09
Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents. Ann Pharmacother (2009) 1.09
Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med (2010) 1.08
The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int (2008) 1.07
Off-Pump Coronary Artery Bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: a United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome. Circulation (2003) 1.07
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells. Exp Cell Res (2005) 1.07
MR imaging of nonmalignant penile lesions. Radiographics (2008) 1.06
Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy. BJU Int (2010) 1.06
Genital lichen sclerosus/balanitis xerotica obliterans in men with penile carcinoma: a critical analysis. BJU Int (2013) 1.05
Testicular histopathology as a predictor of a positive sperm retrieval in men with non-obstructive azoospermia. BJU Int (2012) 1.05
Paraganglioma of the spermatic cord: case report and review of the literature. ScientificWorldJournal (2008) 1.05
Predicting erectile function outcome in men after radical prostatectomy for prostate cancer. BJU Int (2011) 1.05
Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement. Ann Thorac Surg (2004) 1.05
Biomarkers in bladder cancer. Histopathology (2010) 1.04
Molecular architecture of the DNA replication origin activation checkpoint. EMBO J (2010) 1.04
Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study. J Sex Med (2014) 1.02
Total phallic reconstruction in female-to-male transsexuals. Eur Urol (2009) 1.01
The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease. BJU Int (2005) 1.01
Screening of PGPR from saline desert of Kutch: growth promotion in Arachis hypogea by Bacillus licheniformis A2. Microbiol Res (2013) 1.00
Primary prevention and vaccination for penile cancer. Ther Adv Urol (2013) 0.99
Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers. Am J Pathol (2010) 0.99
Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation. Brain Res (2008) 0.98